Literature DB >> 6984025

Thiabendazole (TBZ), an immunohemomodulator. II. Effects on thymocytes and prothymocytes.

E Donskaya, I Goldschneider, J Lundy, R Simon.   

Abstract

The purpose of this study was to document the effects of TBZ on the early stages of T cell maturation. The method utilized to quantify presumptive thymocyte progenitors in the bone marrow used the enzyme terminal deoxynucleotidyl transferase (TdT) as a marker. Shifts in thymocyte populations were determined by quantitative planimetry, immunofluorescence for TdT and tritiated thymidine incorporation. When given alone, TBZ produced a marked increase in the number of large, mitotically active lymphoblasts in the thymus cortex. When given with DNFB, a thymus-dependent neoantigen, TBZ produced a significant increase in TdT-positive bone marrow cells. In a companion study, TBZ + DNFB were found to stimulate T cells in lymph node and spleen. Hence, the results indicate that under appropriate conditions, TBZ can stimulate all stages of T cell differentiation in mice.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6984025     DOI: 10.1016/0192-0561(82)90029-7

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  3 in total

1.  New approaches to immunotherapy: thymomimetic drugs.

Authors:  S Specter; J W Hadden
Journal:  Springer Semin Immunopathol       Date:  1985

2.  The usability of the MRL/1 mouse strain in detection of anti-rheumatic drugs.

Authors:  M L Toivonen; I B Lindén; M Gripenberg; H Vapaatalo
Journal:  Agents Actions       Date:  1984-12

3.  Thiabendazole-induced suppression of renal damage in a murine model of autoimmune disease.

Authors:  S A Elgebaly; F Forouhar; P Dore-Duffy
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.